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Abstract
Background:  Solid tumor metastasis to the epididymis is a rare occurrence and is mostly
discovered incidentally at autopsy or after therapeutic orchidectomy for prostate cancer. Other
primary carcinomas that have been demonstrated to metastasize to the paratesticular region
include those originating in the stomach, kidney, ileum, and colon.
Case presentation: A 72-year-old gentleman presented with a firm and tender mass involving the
right epididymis. On examination, he was jaundiced. Computed tomography of the abdomen
demonstrated an obstructive stricture of the extra-hepatic bile ducts, in keeping with a
cholangiocarcinoma, through which a metal stent was endoscopically inserted for symptomatic
relief.
Subsequent right radical orchidectomy yielded a diffusely infiltrative adenocarcinoma obliterating
the epididymis, extending into the rete testis, vas deferens and spermatic cord and showing
widespread vascular and perineural invasion. Residual epididymal, rete, and testicular tubules
showed no in situ neoplasia. Morphologically and immunohistochemically the features were in
keeping with a metastasis from a primary cholangiocarcinoma.
Conclusion: Only two cases of bile duct carcinoma metastasising to the male genital tract have
previously been reported in the literature, the testis being the main site of metastasis in both cases.
To our knowledge, this is the first described case of cholangiocarcinoma metastasising primarily to
the epididymis, and presenting as a solitary epididymal metastasis in the absence of disseminated
disease. It serves to highlight the importance of performing a thorough examination of the male
external genitalia both clinically, in the follow up of cancer patients, and at autopsy.
Background
Solid tumor metastasis to the testis and paratesticular
region is uncommon and principally encountered as an
incidental autopsy finding [1]. Metastasis to the epidi-
dymis is relatively rare, fewer than fifty cases having been
described in the published literature to date. The majority
of such metastases are of prostatic origin and found inci-
dentally at therapeutic orchidectomy [2]. We report a case
of metastatic cholangiocarcinoma presenting as an epidi-
dymal mass; to our knowledge the first case described in
the English literature.
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Case presentation
A 72-year-old gentleman presented with pain and swell-
ing around the right testis. On admission, he was jaun-
diced. Scrotal examination revealed a firm and tender
mass, separate from the testis, in the region of the epidi-
dymis and distal spermatic cord. Ultrasound examination
showed prominence and thickening of the right epidi-
dymis, normal right testicular appearances, and a right
hydrocele. Computed tomography demonstrated marked
dilatation of the intrahepatic biliary tree extending dis-
tally through the extrahepatic ducts to the confluence of
the left and right hepatic ducts. The common hepatic and
bile ducts were not clearly seen although a subtle infiltrate
encasing the vessels at the porta hepatis was noted. No
other significant pathology affecting the thorax, abdo-
men, or pelvis was seen. Serum bilirubin and alkaline
phosphatase were elevated in keeping with the obstructive
picture. Endoscopic retrograde cholangio-pancreatogra-
phy revealed a long and irregular stricture of the common
bile duct extending into the common hepatic duct. A 150
mm metal stent was inserted to relieve the obstruction
through which bile was subsequently seen to drain effec-
tively. A clinical and radiological diagnosis of cholangi-
ocarcinoma was made.
Subsequently, an uncomplicated right inguinal orchidec-
tomy was undertaken.
Pathology
Macroscopically, the epididymis was obliterated by a firm
white mass (40 × 15 × 13 mm), which extended into the
rete testis and spermatic cord and displaced the adjacent
testis. Histologically, the tumour was composed of epithe-
lial cells showing a focal columnar morphology, forming
glands, trabeculae, and cords, together with scattered indi-
vidual discohesive cells, set within an eosinophilic spin-
dle cell stroma. The tumour cells showed moderate
nuclear pleomorphism and frequent mitotic figures. The
lesion was diffusely infiltrative, extending through the
epididymis (fig 1) and focally into the rete testis, vas def-
erens and spermatic cord. There was very focal interstitial
infiltration into the adjacent testicular parenchyma spar-
ing the seminiferous tubules. Where present, residual
epididymal, rete, and testicular tubules were of normal
appearance, showing no in situ neoplasia. Widespread
vascular and perineural invasion by tumour was present.
Immunohistochemically, the tumour cells showed posi-
tivity for EMA, CEA, Ca125, and CK7 (fig 2) and were neg-
ative for CK20, PSA, PAP, calretinin, and
thrombomodulin. Strong cytoplasmic diastase resistant
PAS positivity was also present.
The appearances were those of an adenocarcinoma. The
differential diagnosis included a primary tumour, arising
from the epididymis or rete testis, or a metastasis. In a
recent paper, Amin et al [3] described features favouring a
metastatic paratesticular tumour including: age greater
than fifty years, a clear history of primary malignancy else-
where, histology not resembling a known, or common,
primary testicular or paratesticular tumour, frequent lym-
phovascular invasion, and an interstitial growth pattern.
On that basis, and in view of the absence of in situ neopla-
sia, a diagnosis of metastatic cholangiocarcinoma was
made.
Unfortunately, the patient subsequently developed ascites
and died from an upper gastrointestinal bleed.
Conclusion
It has been noted that 3.6% of all malignant tumours in
the testis [4] and 8.1% in the paratesticular region are
metastases [5]. They appear to follow a bimodal distribu-
tion with leukaemias and small round blue cell tumours
being more common in childhood and adolescence, and
solid tumours, in particular adenocarcinomas, and lym-
phomas being more common in older men, usually pre-
senting around the sixth decade. Metastatic tumours to
the epididymis are usually identified in the setting of dis-
seminated disease [6] and only uncommonly occur as a
solitary site of metastasis. It is even more rare for an epidi-
dymal metastasis to present as the first manifestation of
an occult primary neoplasm [5,6]. In some cases, metasta-
sis to the testis or paratesticular tissues is the first sign of
tumour recurrence [7], often following definitive treat-
ment. This highlights the importance of examining the
external genitalia in the follow up of all male cancer
patients.
In 1925 Henke and Lubardch were the first to describe
epididymal metastasis from a renal cell carcinoma [8].
Subsequently, in 1927, Keifer noted epididymal spread
from a primary pancreatic carcinoma found incidentally
at autopsy [9]. Since then, up to 50 cases of solid tumour
metastases to the epididymis, with or without spermatic
cord involvement, have been recorded [2]. Many of these
were discovered incidentally at autopsy or on examina-
tion of orchidectomy specimens removed therapeutically
for prostate cancer. The former observation reinforces the
importance of performing a thorough examination of the
male external genitalia at autopsy and the latter explains,
in part, why the prostate has thus far proven to be the
most common primary site for epididymal metastasis
from epithelial tumours (37%) [8]. Other common pri-
mary sites include stomach (18%), kidney (16%), colon
(13%), ileum, particularly carcinoid tumours, (8%), and
pancreas (5%) [8]. Some recent papers, particularly from
Japan, suggest that gastric adenocarcinoma is beginning to
supersede prostatic adenocarcinoma as the most common
primary site for epididymal metastases [3,10] This may be
consequent upon the decline in popularity of orchidec-Diagnostic Pathology 2007, 2:33 http://www.diagnosticpathology.org/content/2/1/33
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Haematoxylin and eosin stained section showing the tumour infiltrating around and into the epididymal tubules, which them- selves show no in situ neoplastic change Figure 1
Haematoxylin and eosin stained section showing the tumour infiltrating around and into the epididymal tubules, which them-
selves show no in situ neoplastic change.
Immunoperoxidase staining for CK7 highlighting the interstitial growth pattern of the tumour within the testicular parenchyma Figure 2
Immunoperoxidase staining for CK7 highlighting the interstitial growth pattern of the tumour within the testicular parenchyma.Publish with BioMed Central    and   every 
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tomy as a therapeutic modality in prostate cancer with the
advent of other less invasive treatments such as hormonal
manipulation.
Proposed routes of metastasis to the epididymis, particu-
larly in the case of a prostatic primary, include direct
extension from adjacent organs and intraductal spread via
the vas deferens. Other proposed mechanisms, more
likely in the case that we describe (particularly in view of
the extensive vascular invasion present within and sur-
rounding the tumour), include retrograde venous and
lymphatic extension, and arterial embolism.
On review of the literature, we found only two cases of
bile duct carcinoma metastasising to the male genital tract
[1,6], the testis being the main site of metastasis in both
cases. To our knowledge, ours is the first case of epididy-
mal metastasis originating from a primary cholangiocarci-
noma of the extrahepatic bile ducts presenting as a solitary
epididymal metastasis in the absence of disseminated dis-
ease.
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